全文获取类型
收费全文 | 2260篇 |
免费 | 133篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 178篇 |
妇产科学 | 30篇 |
基础医学 | 220篇 |
口腔科学 | 58篇 |
临床医学 | 253篇 |
内科学 | 566篇 |
皮肤病学 | 41篇 |
神经病学 | 55篇 |
特种医学 | 500篇 |
外科学 | 213篇 |
综合类 | 29篇 |
预防医学 | 76篇 |
眼科学 | 25篇 |
药学 | 68篇 |
中国医学 | 4篇 |
肿瘤学 | 91篇 |
出版年
2022年 | 10篇 |
2021年 | 23篇 |
2020年 | 20篇 |
2019年 | 17篇 |
2018年 | 42篇 |
2017年 | 22篇 |
2016年 | 33篇 |
2015年 | 36篇 |
2014年 | 62篇 |
2013年 | 87篇 |
2012年 | 67篇 |
2011年 | 67篇 |
2010年 | 87篇 |
2009年 | 76篇 |
2008年 | 62篇 |
2007年 | 50篇 |
2006年 | 63篇 |
2005年 | 38篇 |
2004年 | 43篇 |
2003年 | 44篇 |
2002年 | 40篇 |
2001年 | 28篇 |
2000年 | 45篇 |
1999年 | 43篇 |
1998年 | 136篇 |
1997年 | 126篇 |
1996年 | 132篇 |
1995年 | 93篇 |
1994年 | 75篇 |
1993年 | 84篇 |
1992年 | 30篇 |
1991年 | 35篇 |
1990年 | 26篇 |
1989年 | 62篇 |
1988年 | 53篇 |
1987年 | 60篇 |
1986年 | 48篇 |
1985年 | 53篇 |
1984年 | 26篇 |
1983年 | 32篇 |
1982年 | 36篇 |
1981年 | 21篇 |
1980年 | 37篇 |
1979年 | 16篇 |
1978年 | 17篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1975年 | 25篇 |
1971年 | 8篇 |
1965年 | 10篇 |
排序方式: 共有2418条查询结果,搜索用时 15 毫秒
71.
72.
Infrequent isolation of extensively drug-resistant (XDR) Klebsiella pneumoniae resistant to colistin in Spain 总被引:1,自引:0,他引:1
73.
74.
75.
76.
巨噬细胞迁移抑制因子最初是由于能抑制体外巨噬细胞随机迁移而被发现,现在它作为一种重要的调节因子参与一系列炎症性疾病过程.我们最近发现,巨噬细胞迁移抑制因子的缺失使一些由炎症介质诱发的白细胞-内皮细胞相互作用减弱,提示巨噬细胞迁移抑制因子在炎症反应中起作用的机制之一是促进白细胞聚集.…… 相似文献
77.
Weaver CH; Buckner CD; Longin K; Appelbaum FR; Rowley S; Lilleby K; Miser J; Storb R; Hansen JA; Bensinger W 《Blood》1993,82(7):1981-1984
Five syngeneic transplants were performed in four patients following myeloablative therapy using unmodified peripheral blood mononuclear cells (PBMCs) collected after the administration of recombinant human granulocyte colony stimulating factor (rhG-CSF) to normal donors. The only toxicity experienced by the four normal donors was bone pain. Four patients received two collections of PBMCs, and a second transplant was performed in one patient with one collection. The patients received a median of 20.53 x 10(8) total nucleated cells/kg (range 20 to 25.5), 11.3 x 10(8) total mononuclear cells/kg (range 6.52 to 17.2), 113.1 x 10(4)/kg CFU-GM (range 46.7 to 211.8) and 9.6 x 10(6) CD34+ cells/kg (range 1.6 to 12.6) Post-transplant growth factors were not administered. The median time to an absolute neutrophil count greater than 0.5 x 10(9)/L was 14 days (range 10 to 18). The median time to platelet transfusion independence was 11 days (range 10 to 13). Two patients had the number of CD3+ T lymphocytes determined in the pheresis product. An average of 3.04 x 10(10) CD3+ cells were collected per pheresis. This represents an approximate 1 log increase over the number of T lymphocytes in a typical bone marrow transplant. Rh-GCSF can be used to mobilize peripheral blood progenitor cells from normal donors with minimal toxicity. Studies of allogeneic transplants using PBMCs collected after rhG-CSF administration to determine permanent grafting ability and the incidence and severity of graft-versus-host disease are warranted. 相似文献
78.
79.
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation 总被引:16,自引:17,他引:16
Dunbar CE; Cottler-Fox M; O'Shaughnessy JA; Doren S; Carter C; Berenson R; Brown S; Moen RC; Greenblatt J; Stewart FM 《Blood》1995,85(11):3048-3057
We report here on a preliminary human autologous transplantation study of retroviral gene transfer to bone marrow (BM) and peripheral blood (PB)-derived CD34-enriched cells. Eleven patients with multiple myeloma or breast cancer had cyclophosphamide and filgrastim-mobilized PB cells CD34-enriched and transduced with a retroviral marking vector containing the neomycin resistance gene, and CD34-enriched BM cells transduced with a second marking vector also containing a neomycin resistance gene. After high-dose conditioning therapy, both transduced cell populations were reinfused and patients were followed over time for the presence of the marker gene and any adverse effects related to the gene-transfer procedure. All 10 evaluable patients had the marker gene detected at the time of engraftment, and 3 of 9 patients had persistence of the marker gene for greater than 18 months posttransplantation. The marker gene was detected in multiple lineages, including granulocytes, T cells, and B cells. The source of the marking was both the transduced PB graft and the BM graft, with a suggestion of better long-term marking originating from the PB graft. The steady- state levels of marking were low, with only 1:1000 to 1:10,000 cells positive. There was no toxicity noted, and patients did not develop detectable replication-competent helper virus at any time posttransplantation. These results suggest that mobilized PB cells may be preferable to BM for gene therapy applications and that progeny of mobilized peripheral blood cells can contribute long-term to engraftment of multiple lineages. 相似文献
80.
María del Mar lvarez‐Torres Javier Juan‐Albarracín Elies Fuster‐Garcia Fuensanta Bellvís‐Bataller David Lorente Gaspar Reyns Jaime Font de Mora Fernando Aparici‐Robles Carlos Botella Jose Muoz‐Langa Raquel Faubel Sabina Asensio‐Cuesta Germn A. García‐Ferrando Eduard Chelebian Cristina Auger Jose Pineda Alex Rovira Laura Oleaga Enrique Moll‐Olmos Antonio J. Revert Luaba Tshibanda Girolamo Crisi Kyrre E. Emblem Didier Martin Paulina Due‐Tnnessen Torstein R. Meling Silvano Filice Carlos Sez Juan M. García‐Gmez 《Journal of magnetic resonance imaging : JMRI》2020,51(5):1478-1486